NCT01903434View on ClinicalTrials.gov

A Study of Evacetrapib (LY2484595) in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Evacetrapib

Administered orally

Trial Locations (1)

47710

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Evansville

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01903434 - A Study of Evacetrapib (LY2484595) in Healthy Participants | Biotech Hunter | Biotech Hunter